Randomized Trial for Mixed Acute Rejection

Status Completed

Clinical Trial Summary

This study is being conducted to determine how safe and effective using an immune cell (b cell) depleting therapy and/or Thymoglobulin is in patients with a kidney transplant who are experiencing certain types of rejection.

Clinical Trial Description

The purpose of the study is to determine safety and efficacy of treatment if mixed (cellular and antibody) mediated acute rejection with addition of B-cell depleting therapy to Thymoglobulin in kidney and simultaneous kidney pancreas allograft recipients. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Graft Rejection

Clinical Trial Details

NCT number	NCT00771875
Study type	Interventional
Source	University of Cincinnati
Contact
Status	Completed
Phase	Phase 2
Start date	September 2008
Completion date	March 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00369382` - Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients	Phase 4
Completed	`NCT01009619` - Azithromycin in Bronchiolitis Obliterans Syndrome	Phase 4
Not yet recruiting	`NCT05072951` - Urine Biomarker for Kidney Transplant Rejection
Completed	`NCT01211509` - Montelukast in Bronchiolitis Obliterans Syndrome	Phase 4
Recruiting	`NCT01066689` - Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation	Phase 3
Completed	`NCT00251004` - Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients	Phase 3
Completed	`NCT00254709` - Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients	Phase 4
Recruiting	`NCT04851145` - Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation.	N/A
Completed	`NCT00001984` - Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys	Phase 2
Completed	`NCT04488094` - Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation	Phase 2
Not yet recruiting	`NCT03147157` - The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation	N/A
Completed	`NCT00761787` - Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY	N/A
Completed	`NCT00000137` - Collaborative Corneal Transplantation Studies (CCTS)	Phase 3
Completed	`NCT00266123` - Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients	Phase 4
Completed	`NCT00035555` - Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney	Phase 2
Completed	`NCT00001858` - Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants
Completed	`NCT00895583` - Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients	Phase 4
Completed	`NCT00089947` - A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection	Phase 2
Enrolling by invitation	`NCT05285878` - Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation	Phase 2
Active, not recruiting	`NCT00619528` - HLA-Identical Sibling Renal Transplant Tolerance	N/A